Skip to main content
main-content

Zeitschrift

Infectious Diseases and Therapy

Infectious Diseases and Therapy OnlineFirst articles

11.12.2018 | Original Research Open Access

Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria

Streptococcus pneumoniae ( S. pneumoniae ) is a common gram-positive bacterium with more than 95 serotypes, often colonizing the nasopharynx of healthy infants. S. pneumoniae can spread across the mucosa to cause non-invasive diseases, and …

30.11.2018 | Review Open Access

Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review

Lyme disease or Lyme borreliosis (LB) is caused in humans by at least three genospecies of the Borrelia burgdorferi sensu lato complex: B. burgdorferi , B. garinii and B. afzelii . A bite from an infected Ixodes scapularis and Ixodes pacificus …

21.11.2018 | Original Research Open Access

Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

Staphylococcus aureus bacteremia (SAB) is a common cause of mortality and morbidity and a major burden on healthcare around the world. In patients with positive blood cultures (BC) suggestive of gram-positive cocci in clusters or with a high …

20.11.2018 | Commentary Open Access

Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium

Aktuelle Ausgaben

Über diese Zeitschrift

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Infectious Diseases and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Infectious Diseases and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Upon acceptance of your article for publication, you will be required to pay the article processing charge of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

For more information about the journal, please contact victoria.john@springer.com or see the News page for the latest journal offers.

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise